144 related articles for article (PubMed ID: 30553473)
1. Identification of gene-specific DNA methylation signature for Colorectal Cancer.
Li K; Zeng L; Wei H; Hu J; Jiao L; Zhang J; Xiong Y
Cancer Genet; 2018 Dec; 228-229():5-11. PubMed ID: 30553473
[TBL] [Abstract][Full Text] [Related]
2. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
3. Identification of CD28 and PTEN as novel prognostic markers for cervical cancer.
Shen F; Zheng H; Zhou L; Li W; Liu J; Xu X
J Cell Physiol; 2019 May; 234(5):7004-7011. PubMed ID: 30362552
[TBL] [Abstract][Full Text] [Related]
4. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
5. Field Cancerization in Sporadic Colon Cancer.
Park SK; Song CS; Yang HJ; Jung YS; Choi KY; Koo DH; Kim KE; Jeong KU; Kim HO; Kim H; Chun HK; Park DI
Gut Liver; 2016 Sep; 10(5):773-80. PubMed ID: 27114416
[TBL] [Abstract][Full Text] [Related]
6. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
7. Identification of MSX1 and DCLK1 as mRNA Biomarkers for Colorectal Cancer Detection Through DNA Methylation Information.
Sun AJ; Gao HB; Liu G; Ge HF; Ke ZP; Li S
J Cell Physiol; 2017 Jul; 232(7):1879-1884. PubMed ID: 27966796
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
9. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
[TBL] [Abstract][Full Text] [Related]
10. HPV-related methylation-based reclassification and risk stratification of cervical cancer.
Yang S; Wu Y; Wang S; Xu P; Deng Y; Wang M; Liu K; Tian T; Zhu Y; Li N; Zhou L; Dai Z; Kang H
Mol Oncol; 2020 Sep; 14(9):2124-2141. PubMed ID: 32408396
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
[TBL] [Abstract][Full Text] [Related]
12. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
[TBL] [Abstract][Full Text] [Related]
13. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
14. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Hu C; Zhou Y; Liu C; Kang Y
Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
[TBL] [Abstract][Full Text] [Related]
15. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.
Zhu Y; Lu H; Zhang D; Li M; Sun X; Wan L; Yu D; Tian Y; Jin H; Lin A; Gao F; Lai M
Clin Epigenetics; 2018; 10():30. PubMed ID: 29507648
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of aberrant gene expression and methylation profiles reveals susceptibility genes and underlying mechanism of cervical cancer.
Lin H; Ma Y; Wei Y; Shang H
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():147-152. PubMed ID: 27863272
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.
Müller D; Győrffy B
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188722. PubMed ID: 35307512
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients.
Shalaby SM; El-Shal AS; Abdelaziz LA; Abd-Elbary E; Khairy MM
Gene; 2018 Feb; 644():66-73. PubMed ID: 29080834
[TBL] [Abstract][Full Text] [Related]
19. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
[TBL] [Abstract][Full Text] [Related]
20. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]